Public release date: 12-Sep-2007
Contact: Angela Babb
American Academy of Neurology
Disease activity increases after MS patients stop drug
ST. PAUL, Minn. – People with multiple sclerosis who stop taking the drug natalizumab may experience a rebound increase in disease activity, according to a study published September 12, 2007, in the online edition of Neurology®, the medical journal ...